Lieser Brian 4

Accession 0001193125-25-311352

CIK 0000913142other

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:49 PM ET

Size

38.1 KB

Accession

0001193125-25-311352

Insider Transaction Report

Form 4

Period: 2025-12-04

BELDEN INC.BDC

Lieser Brian

EVP, Solutions

Transactions

Exercise/Conversion
Common Stock
2025-12-04$53.79/sh+2,516$135,336→ 31,590 total
Disposition to Issuer
Common Stock
2025-12-04$120.69/sh−1,759$212,303→ 29,831 total
Exercise/Conversion
Common Stock
2025-12-04$74.91/sh+1,210$90,641→ 31,041 total
Disposition to Issuer
Common Stock
2025-12-04$120.69/sh−961$115,988→ 30,080 total
Exercise/Conversion
Common Stock
2025-12-04$72.73/sh+1,225$89,094→ 31,305 total
Sale
Common Stock
2025-12-05$120.00/sh−1,270$152,400→ 29,074 total
Exercise/Conversion
Stock Appreciation Rights
2025-12-04−1,210→ 0 total
Exercise: $74.91Exp: 2027-02-22→ Common Stock (1,210 underlying)
Exercise/Conversion
Stock Appreciation Rights
2025-12-04−1,225→ 0 total
Exercise: $72.73Exp: 2028-02-28→ Common Stock (1,225 underlying)
Exercise/Conversion
Stock Appreciation Rights
2025-12-04−2,516→ 0 total
Exercise: $53.79Exp: 2032-02-22→ Common Stock (2,516 underlying)

Holdings

Common Stock
(indirect: By 401(k))
505.145

Footnotes (7)

[F1]The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
[F2]Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
[F3]This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
[F4]This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
[F5]This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
[F6]The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
[F7]The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.

Documents

2 files

Issuer

BELDEN INC.

CIK 0000913142

→

Entity typeother

Related Parties

filerCIK 0001967061

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 4:49 PM ET
Size: 38.1 KB

View on SEC.gov